Search results for "Peni"

showing 10 items of 1692 documents

Sodium Chloride and Magnesium Chloride affected by Ripening of Camembert Cheese

1993

Ripening of cheese with three kinds of salt treatment was studied using MgCl 2 , NaCl or a mixture of the two. Proteolysis was followed by determination of TCA-soluble nitrogen and quantitative electrophoresis. A rapid one-step method for free fatty acids was used to determine short and long-chin fatty acids. In the presence of magnesium, proteolysis increased, even with NaCl, which seemed to delay the magnesium activation. Lipolysis was retarded by NaCl, which decreased the level of free fatty acids. An imbalance between proteolysis and lipolysis could be responsible for the unpleasant flavor of the cheese containing both MgCl 2 and NaCl

medicine.diagnostic_testChemistryMagnesiumProteolysisSodiumchemistry.chemical_elementCheese ripeningRipeningBiochemistryCaseinmedicineLipolysisFood scienceFlavorFood ScienceJournal of Food Science
researchProduct

Body composition with dual energy X-ray absorptiometry: from basics to new tools

2020

Dual-energy X-ray absorptiometry (DXA) in nowadays considered one of the most versatile imaging techniques for the evaluation of metabolic bone disorders such as osteoporosis, sarcopenia and obesity. The advantages of DXA over other imaging techniques are the very low radiation dose, its accuracy and simplicity of use. In addition, fat mass (FM) and lean mass (LM) values by DXA shows very good accuracy compared to that of computed tomography and magnetic resonance imaging. In this review we will explain the technical working principles of body composition with DXA, together with the possible limitations and pitfalls that should be avoided in daily routine to produce high-quality DXA examina…

medicine.diagnostic_testIntra-Abdominal Fatbusiness.industryOsteoporosis030209 endocrinology & metabolismMagnetic resonance imagingReview Articlemedicine.diseasemusculoskeletal systemFat mass03 medical and health sciences0302 clinical medicineSarcopeniamedicineLean body massRadiology Nuclear Medicine and imaging030212 general & internal medicineLipodystrophyNuclear medicinebusinesshuman activitiesDual-energy X-ray absorptiometry
researchProduct

Multiple Resistance to Betalactam Antibiotics, Azithromycin or Moxifloxacin in Implant Associated Bacteria

2013

Background Antibiotics are more and more frequently prescribed in dentistry for prevention and treatment of oral diseases. Bacterial resistance to these agents is clearly increasing, including even previously susceptible micro-organisms and true pathogens. The aim of the present investigation was to examine resistant bacterial strains with respect to possible multiple antibiotic resistance. Methods In a previous investigation, implant-associated bacteria were tested first as mixed cultures and again as pure isolates (n = 138) for resistance to one of five antibiotics (ampicillin/AM, ampicillin + sulbactam/AB, azithromycin/AZ, penicillin/PG, moxifloxacin/MX) using the Etest. The resistance o…

medicine.drug_classMoxifloxacinAntibioticsMicrobial Sensitivity TestsDrug resistanceAzithromycinbeta-LactamsGeneral Biochemistry Genetics and Molecular BiologyMicrobiologyAntibiotic resistanceMoxifloxacinAmpicillinmedicineHumansEtestDental ImplantsAza CompoundsBacteriabusiness.industryDrug Resistance MicrobialSulbactamDrug Resistance MultiplePenicillinQuinolinesbusinessFluoroquinolonesmedicine.drugClinical Laboratory
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct

Nutritional Status in Aging and Lung Disease

2016

Abstract Lung diseases exert a negative impact on nutritional status, especially among older patients where aging per se is already associated with relevant changes in nutrient intake, metabolism, and body composition. Both respiratory (increased respiratory work, hypoxia, and local oxidative stress and inflammation) and nonrespiratory (sarcopenia, reduced mitochondrial biogenesis and anabolic hormones, balance of orexigenic/anorexigenic neuropeptides, and systemic inflammation and oxidative stress) contribute to the association between lung diseases and malnutrition. For these reasons, nutritional assessments are of paramount importance in older patients with lung diseases. Current evidenc…

medicine.medical_specialtyAgingPhysiologySettore MED/10 - Malattie Dell'Apparato RespiratorioSystemic inflammationmedicine.disease_causeElderlyOrexigenicInternal medicineVitamin D and neurologyMedicinechemistry.chemical_classificationbusiness.industryMalnutritionHypoxia (medical)medicine.diseaseMalnutritionEndocrinologychemistrySarcopeniaLung diseasemedicine.symptombusinessOxidative stressmedicine.drugPolyunsaturated fatty acid
researchProduct

The biology of the metabolic syndrome and aging.

2015

Aging of the world population is a major contributor to the growing prevalence of the metabolic syndrome, as older persons are frequently affected by the constellation of cardiovascular and metabolic risk factors that constitute the syndrome. The metabolic syndrome has been related to the increasing prevalence of obesity, which is escalating even among older age groups. The present review covers data on the novel proposed biological mediators of the metabolic syndrome, which are as well linked to the aging process.Relevant biological mediators of metabolic syndrome and unhealthy aging include sarcopenic obesity, insulin resistance with ectopic fat accumulation, magnesium metabolism alterati…

medicine.medical_specialtyAgingSarcopeniaMedicine (miscellaneous)Adipose tissue030209 endocrinology & metabolismBiologyBioinformatics03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineObesityMetabolic SyndromeNutrition and DieteticsMetabolic Syndrome XMusclesMetabolic riskmedicine.diseaseObesityEndocrinologyAdipose TissueSarcopeniaAging; Humans; Metabolic Syndrome X; Obesity; Sarcopenia; Adipose Tissue; MusclesMetabolic syndromeHumanCurrent opinion in clinical nutrition and metabolic care
researchProduct

Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management…

2020

Background Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) is often prescribed as the first option, although more recently the use of a quadruple therapy with PPI, bismuth (B), tetracycline (T), and M has been recommended. Aim To evaluate the efficacy and safety of first-line and rescue treatments in patients allergic to penicillin in the "European Registry of H pylori management" (Hp-EuReg). Methods A systematic prospective registry of the clinical practice of European gastroenterologists (27 countries, 300 investigators) on the management of H pylori infect…

medicine.medical_specialtyAllergySettore MED/12 - GASTROENTEROLOGIAallergicPenicillinsGastroenterologyHelicobacter InfectionsDrug Hypersensitivity03 medical and health sciences0302 clinical medicineLevofloxacinMetronidazoleClarithromycinInternal medicinebismuthmedicineHumansProspective StudiesRegistriesAdverse effectlevofloxacinbiologyHelicobacter pyloribusiness.industrySettore MED/09 - MEDICINA INTERNAallergic ; allergy ; bismuth ; clarithromycin ; Helicobacter pylori ; levofloxacin ; penicillinGastroenterologyProton Pump InhibitorsGeneral MedicineTetracyclineHelicobacter pyloribiology.organism_classificationmedicine.diseaseallergyclarithromycinAnti-Bacterial Agents3. Good healthPenicillinMetronidazoleRegimenInfectious Diseasespenicillin030220 oncology & carcinogenesisDrug Therapy Combination030211 gastroenterology & hepatologybusinessmedicine.drug
researchProduct

Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.

2017

Myelodysplastic Syndromes are oligo-clonal stem cell disorders that are associated with cytopenias in the peripheral blood. Major causes for morbidity and mortality in myelodysplastic syndromes (MDS) patients are infections mostly due to bacteria or fungi. Beside leucopenia per se in affected patients, function of white blood cells particularly that of neutrophils seems to be impaired. Here we summarize the available data on infections in MDS patients in general and particularly those treated with 5-azacitidine.

medicine.medical_specialtyAntimetabolites AntineoplasticNeutropeniaAzacitidineInfections03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansIn patientMortalityInfection Controlbusiness.industryMyelodysplastic syndromesHematologyGeneral MedicineAntibiotic Prophylaxismedicine.diseasePeripheral blood030220 oncology & carcinogenesisMyelodysplastic SyndromesAzacitidineStem cellMorbiditybusiness030215 immunologymedicine.drugEuropean journal of haematology
researchProduct

Bone Mineral Density and Bone Metabolism in Diabetes Mellitus

1998

The effect of diabetes mellitus on bone metabolism and bone mineral density is discussed controversially. Diabetes mellitus due to an autoimmune process seems to be associated with low turnover osteopenia either in the animal model or in children and adolescents. A number of factors are discussed as being involved, but in this age group clinical symptoms are missing. Adult patients of either sex with IDDM show a reduced bone mineral density when measured at peripheral sites such as the distal forearm or the femoral neck, diabetic complications such as neuropathy and microangiopathy seem to pronounce the deficit of bone mass. In these patients, osteopenia is accompanied by a high turnover si…

medicine.medical_specialtyBone densityEndocrinology Diabetes and MetabolismClinical BiochemistryOverweightBiochemistryBone and BonesBone remodelingEndocrinologyBone DensityDiabetes mellitusInternal medicinemedicineAnimalsHumansRats Inbred BBFemoral neckBone mineralbusiness.industryBiochemistry (medical)MicroangiopathyGeneral Medicinemedicine.diseaseRatsOsteopeniaDiabetes Mellitus Type 1Endocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2Osteoporosismedicine.symptombusinessHormone and Metabolic Research
researchProduct

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

2016

Objective: To provide meta-analytical evidence of bone mineral density (BMD), fractures, and osteoporosis rates in eating disorders (ED) vs. healthy controls (HCs). Method: Three independent authors searched major electronic databases from inception till August 2015 for cross-sectional studies reporting BMD in people with ED (anorexia nervosa, (AN); bulimia nervosa, (BN); eating disorders not otherwise specified, (EDNOS)) vs. HCs. Standardized mean differences (SMDs) ±95% and confidence intervals (CIs) were calculated for BMD, and odds ratios (ORs) for osteopenia, osteoporosis, and fractures. Results: Overall, 57 studies were eligible, including 21 607 participants (ED = 6485, HCs = 15 122)…

medicine.medical_specialtyBone densityOsteoporosis030209 endocrinology & metabolismComorbidityFeeding and Eating Disorderseating disorders (ED)Fractures Bone03 medical and health sciences0302 clinical medicineBone DensityInternal medicinemedicineHumans030212 general & internal medicineFemoral neckBulimia nervosabusiness.industryAnorexia nervosaOdds ratiomedicine.diseaseOsteopeniaPsychiatry and Mental healthEating disordersmedicine.anatomical_structureBulimia nervosaosteoporosis rateEating disordersPhysical therapyOsteoporosisAmenorrheamedicine.symptomAnorexia nervosa; Bone density; Bulimia nervosa; Eating disorders; Fractures; Psychiatry and Mental Healthbusinessmeta-analytical evidence of bonemineral density (BMD)Fracturesanorexia nervosa; bone density; bulimia nervosa; eating disorders; fracturesActa Psychiatrica Scandinavica
researchProduct